{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T17:37:43Z","timestamp":1791135463005,"version":"4.1.0"},"reference-count":136,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Methods"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.ymeth.2021.12.006","type":"journal-article","created":{"date-parts":[[2021,12,18]],"date-time":"2021-12-18T11:24:23Z","timestamp":1639826663000},"page":"447-464","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Measuring hypertrophy in neonatal rat primary cardiomyocytes and human iPSC-derived cardiomyocytes"],"prefix":"10.1016","volume":"203","author":[{"given":"Kyla","family":"Bourque","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cara","family":"Hawey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jace","family":"Jones-Tabah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darlaine","family":"P\u00e9trin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan D.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Ling Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terence E.","family":"H\u00e9bert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymeth.2021.12.006_b0005","unstructured":"J. King, D.R. Lowery, \u201cPhysiology, Cardiac Output,\u201d in StatPearls. Treasure Island (FL): StatPearls Publishing Copyright \u00a9 2021, StatPearls Publishing LLC., 2021."},{"issue":"14","key":"10.1016\/j.ymeth.2021.12.006_b0010","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1161\/hc3901.095960","article-title":"Exercise standards for testing and training","volume":"104","author":"Fletcher","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ymeth.2021.12.006_b0015","unstructured":"A.B. Bornstein, S.S. Rao, K. Marwaha, Left ventricular hypertrophy, in StatPearls. Treasure Island (FL): StatPearls Publishing."},{"issue":"7","key":"10.1016\/j.ymeth.2021.12.006_b0020","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41569-018-0007-y","article-title":"Mechanisms of physiological and pathological cardiac hypertrophy","volume":"15","author":"Nakamura","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"issue":"1","key":"10.1016\/j.ymeth.2021.12.006_b0025","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev.physiol.65.092101.142243","article-title":"Cardiac hypertrophy: the good, the bad, and the ugly","volume":"65","author":"Frey","year":"2003","journal-title":"Annu. Rev. Physiol."},{"issue":"1","key":"10.1016\/j.ymeth.2021.12.006_b0030","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1136\/heartjnl-2011-300639","article-title":"\u201cPhysiological cardiac remodelling in response to endurance exercise training: cellular and molecular mechanisms,\u201d (in eng)","volume":"98","author":"Ellison","year":"2012","journal-title":"Heart"},{"issue":"4","key":"10.1016\/j.ymeth.2021.12.006_b0035","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/cvr\/cvu013","article-title":"\u201cPregnancy as a cardiac stress model,\u201d (in eng)","volume":"101","author":"Chung","year":"2014","journal-title":"Cardiovasc. Res."},{"issue":"11","key":"10.1016\/j.ymeth.2021.12.006_b0040","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1210\/me.2008-0265","article-title":"\u201cInsulin-like growth factor I receptor signaling is required for exercise-induced cardiac hypertrophy,\u201d (in eng)","volume":"22","author":"Kim","year":"2008","journal-title":"Mol. Endocrinol."},{"issue":"9","key":"10.1016\/j.ymeth.2021.12.006_b0045","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1152\/japplphysiol.00027.2012","article-title":"\u201cAkt and MAPK signaling mediate pregnancy-induced cardiac adaptation,\u201d (in eng)","volume":"112","author":"Chung","year":"1985","journal-title":"J. Appl. Physiol."},{"issue":"11","key":"10.1016\/j.ymeth.2021.12.006_b0050","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1161\/hh2301.100982","article-title":"Increased cardiac sympathetic activity and insulin-like growth factor-I formation are associated with physiological hypertrophy in athletes","volume":"89","author":"Neri Serneri","year":"2001","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.ymeth.2021.12.006_b0055","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrm3495","article-title":"Molecular basis of physiological heart growth: fundamental concepts and new players","volume":"14","author":"Maillet","year":"2013","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"8","key":"10.1016\/j.ymeth.2021.12.006_b0060","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1172\/JCI24682","article-title":"\u201cDisruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure,\u201d (in eng)","volume":"115","author":"Shiojima","year":"2005","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.ymeth.2021.12.006_b0065","doi-asserted-by":"crossref","first-page":"H1552","DOI":"10.1152\/ajpheart.1991.260.5.H1552","article-title":"Loss of intermediate-sized coronary arteries and capillary proliferation after left ventricular failure in rats","volume":"260","author":"Anversa","year":"1991","journal-title":"Am. J. Physiol.-Heart Circul. Physiol."},{"issue":"1","key":"10.1016\/j.ymeth.2021.12.006_b0070","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1146\/annurev.physiol.63.1.391","article-title":"Cytoplasmic signaling pathways that regulate cardiac hypertrophy","volume":"63","author":"Molkentin","year":"2001","journal-title":"Annu. Rev. Physiol."},{"issue":"7","key":"10.1016\/j.ymeth.2021.12.006_b0075","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1161\/CIRCRESAHA.117.311059","article-title":"Hypertrophic cardiomyopathy","volume":"121","author":"Marian","year":"2017","journal-title":"Circ. Res."},{"issue":"5","key":"10.1016\/j.ymeth.2021.12.006_b0080","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/0092-8674(90)90274-I","article-title":"A molecular basis for familial hypertrophic cardiomyopathy: a \u03b2 cardiac myosin heavy chain gene missense mutation","volume":"62","author":"Geisterfer-Lowrance","year":"1990","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.ymeth.2021.12.006_b0085","first-page":"443","article-title":"Sudden cardiac death in hypertrophic cardiomyopathy","volume":"6","author":"O\u2019Mahony","year":"2013","journal-title":"Circulation: Arrhythmia Electrophysiol."},{"issue":"7","key":"10.1016\/j.ymeth.2021.12.006_b0090","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1161\/hh1901.096706","article-title":"Regulation of thyroid hormone receptor isoforms in physiological and pathological cardiac hypertrophy","volume":"89","author":"Kinugawa","year":"2001","journal-title":"Circ. Res."},{"issue":"17","key":"10.1016\/j.ymeth.2021.12.006_b0095","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/j.jacc.2011.07.022","article-title":"\u201cLeft ventricular structural remodeling in health and disease: with special emphasis on volume, mass, and geometry,\u201d (in eng)","volume":"58","author":"Gaasch","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.ymeth.2021.12.006_b0100","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0022-2828(08)80028-4","article-title":"\u201cThe cellular basis of dilated cardiomyopathy in humans,\u201d (in eng)","volume":"27","author":"Beltrami","year":"1995","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"18","key":"10.1016\/j.ymeth.2021.12.006_b0105","doi-asserted-by":"crossref","first-page":"8277","DOI":"10.1073\/pnas.88.18.8277","article-title":"\u201cSegregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy,\u201d (in eng)","volume":"88","author":"Rockman","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ymeth.2021.12.006_b0110","doi-asserted-by":"crossref","unstructured":"A.C. deAlmeida, R.J. van Oort, X.H. Wehrens, \u201cTransverse aortic constriction in mice,\u201d (in eng), J Vis Exp, 38, 2010,.","DOI":"10.3791\/1729"},{"issue":"1","key":"10.1016\/j.ymeth.2021.12.006_b0115","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-42209-7","article-title":"Distinct phenotypes induced by three degrees of transverse aortic constriction in mice","volume":"9","author":"Richards","year":"2019","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.ymeth.2021.12.006_b0120","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1073\/pnas.95.6.2979","article-title":"\u201cHL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte,\u201d (in eng)","volume":"95","author":"Claycomb","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"2","key":"10.1016\/j.ymeth.2021.12.006_b0125","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s11626-010-9368-1","article-title":"The H9C2 cell line and primary neonatal cardiomyocyte cells show similar hypertrophic responses in vitro","volume":"47","author":"Watkins","year":"2011","journal-title":"In Vitro Cell. Develop. Biol. - Animal"},{"issue":"14","key":"10.1016\/j.ymeth.2021.12.006_b0130","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1091\/mbc.E16-01-0038","article-title":"Biology of the cardiac myocyte in heart disease","volume":"27","author":"Peter","year":"2016","journal-title":"Mol. Biol. Cell"},{"issue":"2","key":"10.1016\/j.ymeth.2021.12.006_b0135","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/0014-4827(76)90447-X","article-title":"\u201cProperties of a clonal muscle cell line from rat heart,\u201d (in eng)","volume":"98","author":"Kimes","year":"1976","journal-title":"Exp. Cell Res."},{"issue":"1","key":"10.1016\/j.ymeth.2021.12.006_b0140","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.bbrc.2004.09.067","article-title":"Transforming growth factor-\u03b2 induces the expression of ANF and hypertrophic growth in cultured cardiomyoblast cells through ZAK","volume":"324","author":"Huang","year":"2004","journal-title":"Biochem. Biophys. Res. Commun"},{"issue":"3","key":"10.1016\/j.ymeth.2021.12.006_b0145","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.bbrc.2004.09.156","article-title":"\u201cZAK re-programs atrial natriuretic factor expression and induces hypertrophic growth in H9c2 cardiomyoblast cells,\u201d (in eng)","volume":"324","author":"Huang","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.ymeth.2021.12.006_b0150","doi-asserted-by":"crossref","first-page":"H821","DOI":"10.1152\/ajpheart.00345.2009","article-title":"Dose-dependent activation of distinct hypertrophic pathways by serotonin in cardiac cells","volume":"297","author":"Villeneuve","year":"2009","journal-title":"Am. J. Physiol.-Heart Circul. Physiol."},{"issue":"4","key":"10.1016\/j.ymeth.2021.12.006_b0155","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s00210-004-0980-z","article-title":"Urotensin-II-mediated cardiomyocyte hypertrophy: effect of receptor antagonism and role of inflammatory mediators","volume":"370","author":"Johns","year":"2004","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"issue":"6","key":"10.1016\/j.ymeth.2021.12.006_b0160","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1161\/01.RES.69.6.1487","article-title":"\u201cL-type calcium channels, potassium channels, and novel nonspecific cation channels in a clonal muscle cell line derived from embryonic rat ventricle,\u201d (in eng)","volume":"69","author":"Sipido","year":"1991","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.ymeth.2021.12.006_b0165","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1161\/01.RES.69.6.1476","article-title":"\u201cMorphological, biochemical, and electrophysiological characterization of a clonal cell (H9c2) line from rat heart,\u201d (in eng)","volume":"69","author":"Hescheler","year":"1991","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.ymeth.2021.12.006_b0170","doi-asserted-by":"crossref","first-page":"H823","DOI":"10.1152\/ajpheart.00986.2003","article-title":"Cardiac physiology at the cellular level: use of cultured HL-1 cardiomyocytes for studies of cardiac muscle cell structure and function","volume":"286","author":"White","year":"2004","journal-title":"Am. J. Physiol.-Heart Circul. Physiol."},{"issue":"2","key":"10.1016\/j.ymeth.2021.12.006_b0175","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1161\/CIRCHEARTFAILURE.110.958694","article-title":"\u201cJunctophilin-2 expression silencing causes cardiocyte hypertrophy and abnormal intracellular calcium-handling,\u201d (in eng)","volume":"4","author":"Landstrom","year":"2011","journal-title":"Circ. Heart Fail."},{"issue":"6","key":"10.1016\/j.ymeth.2021.12.006_b0180","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1073\/pnas.95.6.2979","article-title":"HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte","volume":"95","author":"Claycomb","year":"1998","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"5","key":"10.1016\/j.ymeth.2021.12.006_b0185","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1007\/s10616-016-0001-3","article-title":"\u201cReal-time monitoring of hypertrophy in HL-1 cardiomyocytes by impedance measurements reveals different modes of growth,\u201d (in eng)","volume":"68","author":"Bloch","year":"2016","journal-title":"Cytotechnology"},{"issue":"6","key":"10.1016\/j.ymeth.2021.12.006_b0190","doi-asserted-by":"crossref","first-page":"C425","DOI":"10.1152\/ajpcell.00058.2015","article-title":"cAMP induces hypertrophy and alters DNA methylation in HL-1 cardiomyocytes","volume":"309","author":"Fang","year":"2015","journal-title":"Am. J. Physiol.-Cell Physiol."},{"issue":"3","key":"10.1016\/j.ymeth.2021.12.006_b0195","first-page":"873","article-title":"Pyrroloquinoline quinone attenuates isoproterenol hydrochloride-induced cardiac hypertrophy in AC16 cells by inhibiting the NF-\u03baB signaling pathway","volume":"45","author":"Wen","year":"2020","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.ymeth.2021.12.006_b0200","doi-asserted-by":"crossref","DOI":"10.1093\/abbs\/gmz119","article-title":"UBE3A alleviates isoproterenol-induced cardiac hypertrophy through the inhibition of the TLR4\/MMP-9 signaling pathway","author":"Li","year":"2019","journal-title":"Acta Biochim. Biophy. Sin."},{"key":"10.1016\/j.ymeth.2021.12.006_b0205","doi-asserted-by":"crossref","unstructured":"D. Li, J. Wu, Y. Bai, X. Zhao, L. Liu, \u201cIsolation and culture of adult mouse cardiomyocytes for cell signaling and in vitro cardiac hypertrophy,\u201d (in eng), J. Vis. Exp., 87, 2014, 10.3791\/51357.","DOI":"10.3791\/51357-v"},{"issue":"8","key":"10.1016\/j.ymeth.2021.12.006_b0210","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1161\/CIRCRESAHA.107.164947","article-title":"Epac mediates & #x3b2;-adrenergic receptor\u2013induced cardiomyocyte hypertrophy","volume":"102","author":"M\u00e9trich","year":"2008","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.ymeth.2021.12.006_b0215","doi-asserted-by":"crossref","first-page":"C495","DOI":"10.1152\/ajpcell.2000.279.2.C495","article-title":"Hypertrophic effect of selective \u03b21-adrenoceptor stimulation on ventricular cardiomyocytes from adult rat","volume":"279","author":"Sch\u00e4fer","year":"2000","journal-title":"Am. J. Physiol.-Cell Physiol."},{"key":"10.1016\/j.ymeth.2021.12.006_b0220","series-title":"The Scientist's Guide to Cardiac Metabolism","first-page":"103","article-title":"Chapter 8 - Models to investigate cardiac metabolism","author":"Schwarzer","year":"2016"},{"issue":"2","key":"10.1016\/j.ymeth.2021.12.006_b0225","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0092-8674(00)81573-1","article-title":"\u201cA calcineurin-dependent transcriptional pathway for cardiac hypertrophy,\u201d (in eng)","volume":"93","author":"Molkentin","year":"1998","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.ymeth.2021.12.006_b0230","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1083\/jcb.142.2.523","article-title":"\u201cStimulation of the p38 mitogen-activated protein kinase pathway in neonatal rat ventricular myocytes by the G protein-coupled receptor agonists, endothelin-1 and phenylephrine: a role in cardiac myocyte hypertrophy?,\u201d (in eng)","volume":"142","author":"Clerk","year":"1998","journal-title":"J. Cell Biol."},{"issue":"2","key":"10.1016\/j.ymeth.2021.12.006_b0235","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.yjmcc.2012.04.016","article-title":"\u201cAutomated imaging reveals a concentration dependent delay in reversibility of cardiac myocyte hypertrophy,\u201d (in eng)","volume":"53","author":"Ryall","year":"2012","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"6","key":"10.1016\/j.ymeth.2021.12.006_b0240","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1074\/jbc.271.6.3221","article-title":"Endothelin-1 is involved in mechanical stress-induced cardiomyocyte hypertrophy (\u2217)","volume":"271","author":"Yamazaki","year":"1996","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.ymeth.2021.12.006_b0245","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.molcel.2009.02.005","article-title":"\u201cEndothelin-1-stimulated InsP3-induced Ca2+ release is a nexus for hypertrophic signaling in cardiac myocytes,\u201d (in eng)","volume":"33","author":"Higazi","year":"2009","journal-title":"Mol. Cell"},{"issue":"48","key":"10.1016\/j.ymeth.2021.12.006_b0250","doi-asserted-by":"crossref","first-page":"37895","DOI":"10.1074\/jbc.M007037200","article-title":"\u201cExtracellular signal-regulated kinase plays an essential role in hypertrophic agonists, endothelin-1 and phenylephrine-induced cardiomyocyte hypertrophy,\u201d (in eng)","volume":"275","author":"Yue","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.ymeth.2021.12.006_b0255","doi-asserted-by":"crossref","first-page":"C310","DOI":"10.1152\/ajpcell.00060.2017","article-title":"Neonatal cardiomyocyte hypertrophy induced by endothelin-1 is blocked by estradiol acting on GPER","volume":"314","author":"Goncalves","year":"2018","journal-title":"Am. J. Physiol.-Cell Physiol."},{"issue":"8","key":"10.1016\/j.ymeth.2021.12.006_b0260","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/j.bios.2006.07.032","article-title":"A novel microfluidic impedance assay for monitoring endothelin-induced cardiomyocyte hypertrophy","volume":"22","author":"Yang","year":"2007","journal-title":"Biosens. Bioelectron."},{"issue":"1","key":"10.1016\/j.ymeth.2021.12.006_b0265","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1172\/JCI116579","article-title":"\u201cEndothelin-1 is an autocrine\/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes,\u201d (in eng)","volume":"92","author":"Ito","year":"1993","journal-title":"J. Clin. Invest."},{"issue":"Suppl 3","key":"10.1016\/j.ymeth.2021.12.006_b0270","doi-asserted-by":"crossref","first-page":"S100","DOI":"10.1097\/00005344-199526003-00031","article-title":"\u201cEndothelin-1-induced phospholipase C-beta and D and protein kinase C isoenzyme signaling leading to hypertrophy in rat cardiomyocytes,\u201d (in eng)","volume":"26","author":"Lamers","year":"1995","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ymeth.2021.12.006_b0275","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.cellsig.2017.04.010","article-title":"\u201cEndothelin-1 promotes hypertrophic remodelling of cardiac myocytes by activating sustained signalling and transcription downstream of endothelin type A receptors,\u201d (in eng)","volume":"36","author":"Archer","year":"2017","journal-title":"Cell. Signal."},{"issue":"7","key":"10.1016\/j.ymeth.2021.12.006_b0280","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1161\/01.CIR.0000112596.06954.00","article-title":"Endothelin-1\u2013induced cardiac hypertrophy is inhibited by activation of peroxisome proliferator\u2013activated receptor-\u03b1 partly via blockade of c-Jun NH<sub>2<\/sub>-terminal kinase pathway","volume":"109","author":"Irukayama-Tomobe","year":"2004","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.ymeth.2021.12.006_b0285","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1161\/01.RES.56.6.884","article-title":"Stimulation of hypertrophy of cultured neonatal rat heart cells through an alpha 1-adrenergic receptor and induction of beating through an alpha 1- and beta 1-adrenergic receptor interaction. Evidence for independent regulation of growth and beating.","volume":"56","author":"Simpson","year":"1985","journal-title":"Circ. Res."},{"issue":"4","key":"10.1016\/j.ymeth.2021.12.006_b0290","doi-asserted-by":"crossref","first-page":"C926","DOI":"10.1152\/ajpcell.00254.2001","article-title":"\u201cRole of reactive oxygen species and NAD(P)H oxidase in alpha(1)-adrenoceptor signaling in adult rat cardiac myocytes,\u201d (in eng)","volume":"282","author":"Xiao","year":"2002","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"6","key":"10.1016\/j.ymeth.2021.12.006_b0295","doi-asserted-by":"crossref","first-page":"C2269","DOI":"10.1152\/ajpcell.00441.2006","article-title":"Phenylephrine hypertrophy, Ca2+-ATPase (SERCA2), and Ca2+ signaling in neonatal rat cardiac myocytes","volume":"292","author":"Prasad","year":"2007","journal-title":"Am. J. Physiol.-Cell Physiol."},{"issue":"1","key":"10.1016\/j.ymeth.2021.12.006_b0300","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.cardiores.2006.02.032","article-title":"JunD attenuates phenylephrine-mediated cardiomyocyte hypertrophy by negatively regulating AP-1 transcriptional activity","volume":"71","author":"Hilfikerkleiner","year":"2006","journal-title":"Cardiovasc. Res."},{"issue":"3","key":"10.1016\/j.ymeth.2021.12.006_b0305","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1161\/01.RES.75.3.418","article-title":"Acute changes in myosin heavy chain synthesis rate in pressure versus volume overload.","volume":"75","author":"Imamura","year":"1994","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.ymeth.2021.12.006_b0310","first-page":"H2176","article-title":"\u201cTranslational mechanisms accelerate the rate of protein synthesis during canine pressure-overload hypertrophy,\u201d (in eng)","volume":"277","author":"Nagatomo","year":"1999","journal-title":"Am. J. Physiol."},{"issue":"14","key":"10.1016\/j.ymeth.2021.12.006_b0315","doi-asserted-by":"crossref","DOI":"10.1128\/MCB.00048-20","article-title":"Differential activation of P-TEFb complexes in the development of cardiomyocyte hypertrophy following activation of distinct G protein-coupled receptors","volume":"40","author":"Martin","year":"2020","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ymeth.2021.12.006_b0320","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.cellsig.2018.01.002","article-title":"\u201cReceptor- and cellular compartment-specific activation of the cAMP\/PKA pathway by \u03b1(1)-adrenergic and ETA endothelin receptors,\u201d (in eng)","volume":"44","author":"Martin","year":"2018","journal-title":"Cell. Signal."},{"issue":"6","key":"10.1016\/j.ymeth.2021.12.006_b0325","doi-asserted-by":"crossref","first-page":"H2471","DOI":"10.1152\/ajpheart.1994.267.6.H2471","article-title":"Transition from compensatory hypertrophy to dilated, failing left ventricles in Dahl salt-sensitive rats","volume":"267","author":"Inoko","year":"1994","journal-title":"Am. J. Physiol.-Heart Circul. Physiol."},{"issue":"1","key":"10.1016\/j.ymeth.2021.12.006_b0330","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0008-6363(98)00110-2","article-title":"Animal models of human cardiovascular disease, heart failure and hypertrophy","volume":"39","author":"Hasenfuss","year":"1998","journal-title":"Cardiovasc. Res."},{"issue":"1","key":"10.1016\/j.ymeth.2021.12.006_b0335","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-21548-x","article-title":"Experimental modelling of cardiac pressure overload hypertrophy: modified technique for precise, reproducible, safe and easy aortic arch banding-debanding in mice","volume":"8","author":"Merino","year":"2018","journal-title":"Sci. Rep."},{"issue":"1\u20132","key":"10.1016\/j.ymeth.2021.12.006_b0340","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0014-5793(93)80476-B","article-title":"\u201cIncreased production of endothelin-1 in the hypertrophied rat heart due to pressure overload,\u201d (in eng)","volume":"332","author":"Yorikane","year":"1993","journal-title":"FEBS Lett."},{"issue":"5363","key":"10.1016\/j.ymeth.2021.12.006_b0345","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1126\/science.280.5363.574","article-title":"Targeting the receptor-Gq interface to inhibit in vivo pressure overload myocardial hypertrophy","volume":"280","author":"Akhter","year":"1998","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.ymeth.2021.12.006_b0350","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/nm1101-1236","article-title":"Absence of pressure overload induced myocardial hypertrophy after conditional inactivation of G\u03b1 q\/G\u03b1 11 in cardiomyocytes","volume":"7","author":"Wettschureck","year":"2001","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.ymeth.2021.12.006_b0355","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1161\/01.HYP.0000035397.73223.CE","article-title":"\u201cGq-coupled receptor agonists mediate cardiac hypertrophy via the vasculature,\u201d (in eng)","volume":"40","author":"Keys","year":"2002","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.ymeth.2021.12.006_b0360","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1161\/01.RES.78.4.517","article-title":"Adverse effects of chronic endogenous sympathetic drive induced by cardiac G<sub>s\u03b1<\/sub> overexpression","volume":"78","author":"Iwase","year":"1996","journal-title":"Circ. Res."},{"issue":"12","key":"10.1016\/j.ymeth.2021.12.006_b0365","doi-asserted-by":"crossref","first-page":"7059","DOI":"10.1073\/pnas.96.12.7059","article-title":"\u201cProgressive hypertrophy and heart failure in beta1-adrenergic receptor transgenic mice,\u201d (in eng)","volume":"96","author":"Engelhardt","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"3","key":"10.1016\/j.ymeth.2021.12.006_b0370","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1161\/hc0302.103712","article-title":"Pivotal role of a gp91<sup>phox<\/sup>-containing NADPH oxidase in angiotensin II-induced cardiac hypertrophy in mice","volume":"105","author":"Bendall","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ymeth.2021.12.006_b0375","doi-asserted-by":"crossref","unstructured":"R. Li, Y. Shan, L. Gao, X. Wang, X. Wang, F. Wang, \u201cThe Glp-1 analog liraglutide protects against angiotensin II and pressure overload-induced cardiac hypertrophy via PI3K\/Akt1 and AMPKa signaling,\u201d (in English), Front. Pharmacol., Original Research 10(537), 2019, 10.3389\/fphar.2019.00537.","DOI":"10.3389\/fphar.2019.00537"},{"issue":"3","key":"10.1016\/j.ymeth.2021.12.006_b0380","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.jmb.2007.10.006","article-title":"\u201cPrevention of cardiac hypertrophy and heart failure by silencing of NF-kappaB,\u201d (in eng)","volume":"375","author":"Gupta","year":"2008","journal-title":"J. Mol. Biol."},{"issue":"3","key":"10.1016\/j.ymeth.2021.12.006_b0385","first-page":"70","article-title":"\u201cSmall mammalian animal models of heart disease,\u201d (in eng)","volume":"6","author":"Camacho","year":"2016","journal-title":"Am. J. Cardiovasc. Dis."},{"issue":"3","key":"10.1016\/j.ymeth.2021.12.006_b0390","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/00001573-200005000-00012","article-title":"Animal models of hypertrophic cardiomyopathy:","volume":"15","author":"Maass","year":"2000","journal-title":"Curr. Opin. Cardiol."},{"issue":"1","key":"10.1016\/j.ymeth.2021.12.006_b0395","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0008-6363(98)00076-5","article-title":"Rat models of hypertension, cardiac hypertrophy and failure","volume":"39","author":"Doggrell","year":"1998","journal-title":"Cardiovasc. Res."},{"issue":"2","key":"10.1016\/j.ymeth.2021.12.006_b0400","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.yjmcc.2010.10.029","article-title":"\u201cModulation of human embryonic stem cell-derived cardiomyocyte growth: a testbed for studying human cardiac hypertrophy?,\u201d (in eng)","volume":"50","author":"F\u00f6ldes","year":"2011","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"3","key":"10.1016\/j.ymeth.2021.12.006_b0405","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.stemcr.2018.01.016","article-title":"\u201cModeling human cardiac hypertrophy in stem cell-derived cardiomyocytes,\u201d (in eng)","volume":"10","author":"Ovchinnikova","year":"2018","journal-title":"Stem Cell Rep."},{"issue":"15","key":"10.1016\/j.ymeth.2021.12.006_b0410","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJMoa0908679","article-title":"\u201cPatient-specific induced pluripotent stem-cell models for long-QT syndrome,\u201d (in eng)","volume":"363","author":"Moretti","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.ymeth.2021.12.006_b0415","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jacc.2014.04.057","article-title":"\u201cGenome editing of isogenic human induced pluripotent stem cells recapitulates long QT phenotype for drug testing,\u201d (in eng)","volume":"64","author":"Wang","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.ymeth.2021.12.006_b0420","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.stemcr.2019.06.007","article-title":"\u201cPhenotype-based high-throughput classification of long QT syndrome subtypes using human induced pluripotent stem cells,\u201d (in eng)","volume":"13","author":"Yoshinaga","year":"2019","journal-title":"Stem Cell Rep."},{"issue":"5","key":"10.1016\/j.ymeth.2021.12.006_b0425","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1242\/dmm.019505","article-title":"Modeling and study of the mechanism of dilated cardiomyopathy using induced pluripotent stem cells derived from individuals with Duchenne muscular dystrophy","volume":"8","author":"Lin","year":"2015","journal-title":"Dis. Models Mech."},{"issue":"1","key":"10.1016\/j.ymeth.2021.12.006_b0430","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aap9004","article-title":"\u201cCorrection of diverse muscular dystrophy mutations in human engineered heart muscle by single-site genome editing,\u201d","volume":"4","author":"Long","year":"2018","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ymeth.2021.12.006_b0435","doi-asserted-by":"crossref","unstructured":"C. Sun et al., \u201cDuchenne muscular dystrophy hiPSC-derived myoblast drug screen identifies compounds that ameliorate disease in mdx mice,\u201d (in eng), JCI Insight, 5(11), 2020, 10.1172\/jci.insight.134287.","DOI":"10.1172\/jci.insight.134287"},{"issue":"7435","key":"10.1016\/j.ymeth.2021.12.006_b0440","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nature11799","article-title":"\u201cStudying arrhythmogenic right ventricular dysplasia with patient-specific iPSCs,\u201d (in eng)","volume":"494","author":"Kim","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.ymeth.2021.12.006_b0445","doi-asserted-by":"crossref","unstructured":"D. Ma et al., \u201cGeneration of patient-specific induced pluripotent stem cell-derived cardiomyocytes as a cellular model of arrhythmogenic right ventricular cardiomyopathy,\u201d (in eng), Eur. Heart J., 34(15), 1122-33, 2013, 10.1093\/eurheartj\/ehs226.","DOI":"10.1093\/eurheartj\/ehs226"},{"issue":"130","key":"10.1016\/j.ymeth.2021.12.006_b0450","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003552","article-title":"Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy","volume":"4","author":"Sun","year":"2012","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.ymeth.2021.12.006_b0455","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.stem.2015.04.020","article-title":"\u201cEpigenetic regulation of phosphodiesterases 2A and 3A underlies compromised \u03b2-adrenergic signaling in an iPSC model of dilated cardiomyopathy,\u201d (in eng)","volume":"17","author":"Wu","year":"2015","journal-title":"Cell Stem Cell"},{"issue":"1","key":"10.1016\/j.ymeth.2021.12.006_b0460","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.stem.2012.10.010","article-title":"\u201cAbnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells,\u201d (in eng)","volume":"12","author":"Lan","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ymeth.2021.12.006_b0465","doi-asserted-by":"crossref","unstructured":"L. Han et al., \u201cStudy familial hypertrophic cardiomyopathy using patient-specific induced pluripotent stem cells,\u201d Cardiovas. Res., 104(2), 258-269, 2014, 10.1093\/cvr\/cvu205.","DOI":"10.1093\/cvr\/cvu205"},{"issue":"5","key":"10.1016\/j.ymeth.2021.12.006_b0470","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/nm.4087","article-title":"\u201cHuman induced pluripotent stem cell-derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity,\u201d (in eng)","volume":"22","author":"Burridge","year":"2016","journal-title":"Nat. Med."},{"issue":"7","key":"10.1016\/j.ymeth.2021.12.006_b0475","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1152\/physiolgenomics.00021.2020","article-title":"Silencing of MYH7 ameliorates disease phenotypes in human iPSC-cardiomyocytes","volume":"52","author":"Dainis","year":"2020","journal-title":"Physiol. Genomics"},{"issue":"12","key":"10.1016\/j.ymeth.2021.12.006_b0480","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201911115","article-title":"Disease modeling of a mutation in \u03b1-actinin 2 guides clinical therapy in hypertrophic cardiomyopathy","volume":"11","author":"Prondzynski","year":"2019","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ymeth.2021.12.006_b0485","doi-asserted-by":"crossref","unstructured":"A.S. Vander Roest et al., \u201cHypertrophic cardiomyopathy \u03b2-cardiac myosin mutation (P710R) leads to hypercontractility by disrupting super relaxed state,\u201d Proc. Natl. Acad. Sci., 118(24), p. e2025030118, 2021, 10.1073\/pnas.2025030118.","DOI":"10.1073\/pnas.2025030118"},{"issue":"1","key":"10.1016\/j.ymeth.2021.12.006_b0490","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.stem.2012.10.010","article-title":"Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells","volume":"12","author":"Lan","year":"2013","journal-title":"Cell Stem Cell"},{"issue":"5","key":"10.1016\/j.ymeth.2021.12.006_b0495","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s12265-019-09873-6","article-title":"\u201cInduced pluripotent stem cell-derived cardiomyocytes from a patient with MYL2-R58Q-mediated apical hypertrophic cardiomyopathy show hypertrophy, myofibrillar disarray, and calcium perturbations","volume":"12","author":"Zhou","year":"2019","journal-title":"J. Cardiovas. Transl. Res."},{"key":"10.1016\/j.ymeth.2021.12.006_b0500","doi-asserted-by":"crossref","unstructured":"L. Han et al., \u201cStudy familial hypertrophic cardiomyopathy using patient-specific induced pluripotent stem cells,\u201d (in eng), Cardiovasc. Res., 104(2), pp. 258-69, 2014, 10.1093\/cvr\/cvu205.","DOI":"10.1093\/cvr\/cvu205"},{"issue":"6","key":"10.1016\/j.ymeth.2021.12.006_b0505","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001263","article-title":"Endothelin\u20101 induces myofibrillar disarray and contractile vector variability in hypertrophic cardiomyopathy\u2013induced pluripotent stem cell\u2013derived cardiomyocytes","volume":"3","author":"Tanaka","year":"2014","journal-title":"J. Am. Heart Assoc."},{"issue":"3","key":"10.1016\/j.ymeth.2021.12.006_b0510","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1128\/MCB.25.3.865-878.2005","article-title":"\u201cDirect and indirect interactions between calcineurin-NFAT and MEK1-extracellular signal-regulated kinase 1\/2 signaling pathways regulate cardiac gene expression and cellular growth,\u201d (in eng)","volume":"25","author":"Sanna","year":"2005","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ymeth.2021.12.006_b0515","doi-asserted-by":"crossref","unstructured":"M. Johansson et al., \u201cCardiac hypertrophy in a dish: a human stem cell based model,\u201d (in eng), Biol Open, 9(9), 2020, 10.1242\/bio.052381.","DOI":"10.1242\/bio.052381"},{"issue":"3","key":"10.1016\/j.ymeth.2021.12.006_b0520","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.stemcr.2021.01.018","article-title":"Maturation of pluripotent stem cell-derived cardiomyocytes enables modeling of human hypertrophic cardiomyopathy","volume":"16","author":"Knight","year":"2021","journal-title":"Stem Cell Rep."},{"issue":"8","key":"10.1016\/j.ymeth.2021.12.006_b0525","doi-asserted-by":"crossref","first-page":"e43179","DOI":"10.1371\/journal.pone.0043179","article-title":"Role of endothelin in the induction of cardiac hypertrophy in vitro","volume":"7","author":"Bupha-Intr","year":"2012","journal-title":"PLoS ONE"},{"issue":"10","key":"10.1016\/j.ymeth.2021.12.006_b0530","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1161\/CIRCRESAHA.109.198515","article-title":"Role of Ca2+\/calmodulin-stimulated cyclic nucleotide phosphodiesterase 1 in mediating cardiomyocyte hypertrophy","volume":"105","author":"Miller","year":"2009","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.ymeth.2021.12.006_b0535","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.cell.2013.07.013","article-title":"BET bromodomains mediate transcriptional pause release in heart failure","volume":"154","author":"Anand","year":"2013","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.ymeth.2021.12.006_b0540","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-08713-4","article-title":"Distinct carbon sources affect structural and functional maturation of cardiomyocytes derived from human pluripotent stem cells","volume":"7","author":"Correia","year":"2017","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.ymeth.2021.12.006_b0545","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.stemcr.2014.09.002","article-title":"\u201cAberrant \u03b1-adrenergic hypertrophic response in cardiomyocytes from human induced pluripotent cells,\u201d (in eng)","volume":"3","author":"F\u00f6ldes","year":"2014","journal-title":"Stem Cell Rep."},{"issue":"8","key":"10.1016\/j.ymeth.2021.12.006_b0550","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1111\/jcmm.12356","article-title":"\u201cSerum supplemented culture medium masks hypertrophic phenotypes in human pluripotent stem cell derived cardiomyocytes,\u201d (in eng)","volume":"18","author":"Dambrot","year":"2014","journal-title":"J. Cell Mol. Med."},{"issue":"10","key":"10.1016\/j.ymeth.2021.12.006_b0555","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1177\/1087057113500812","article-title":"Phenotypic screening with human iPS cell-derived cardiomyocytes: HTS-compatible assays for interrogating cardiac hypertrophy","volume":"18","author":"Carlson","year":"2013","journal-title":"J. Biomol. Screen."},{"key":"10.1016\/j.ymeth.2021.12.006_b0560","doi-asserted-by":"crossref","unstructured":"C. X. Chen et al., \u201cA multistep workflow to evaluate newly generated iPSCs and their ability to generate different cell types,\u201d (in eng), Methods Protoc, 4(30, 2021, 10.3390\/mps4030050.","DOI":"10.3390\/mps4030050"},{"issue":"4","key":"10.1016\/j.ymeth.2021.12.006_b0565","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"\u201cInduction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors,\u201d (in eng)","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.ymeth.2021.12.006_b0570","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"\u201cInduction of pluripotent stem cells from adult human fibroblasts by defined factors,\u201d (in eng)","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"},{"issue":"23","key":"10.1016\/j.ymeth.2021.12.006_b0575","doi-asserted-by":"crossref","first-page":"9685","DOI":"10.1073\/pnas.0702859104","article-title":"Biphasic role for Wnt\/\u03b2-catenin signaling in cardiac specification in zebrafish and embryonic stem cells","volume":"104","author":"Ueno","year":"2007","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"2","key":"10.1016\/j.ymeth.2021.12.006_b0580","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1161\/CIRCRESAHA.110.221531","article-title":"The multiple phases and faces of wnt signaling during cardiac differentiation and development","volume":"107","author":"Gessert","year":"2010","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.ymeth.2021.12.006_b0585","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.devcel.2007.06.006","article-title":"Wnt\/\u03b2-catenin signaling and cardiogenesis: timing does matter","volume":"13","author":"Tzahor","year":"2007","journal-title":"Dev. Cell"},{"issue":"23","key":"10.1016\/j.ymeth.2021.12.006_b0590","doi-asserted-by":"crossref","first-page":"9685","DOI":"10.1073\/pnas.0702859104","article-title":"\u201cBiphasic role for Wnt\/beta-catenin signaling in cardiac specification in zebrafish and embryonic stem cells,\u201d (in eng)","volume":"104","author":"Ueno","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"4","key":"10.1016\/j.ymeth.2021.12.006_b0595","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.stemcr.2016.08.008","article-title":"\u201cDistinctive roles of canonical and noncanonical wnt signaling in human embryonic cardiomyocyte development,\u201d (in eng)","volume":"7","author":"Mazzotta","year":"2016","journal-title":"Stem Cell Rep."},{"issue":"1","key":"10.1016\/j.ymeth.2021.12.006_b0600","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-02812-6","article-title":"\u201cCardiogenic programming of human pluripotent stem cells by dose-controlled activation of EOMES,\u201d","volume":"9","author":"Pfeiffer","year":"2018","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.ymeth.2021.12.006_b0605","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.stem.2015.11.019","article-title":"\u201cStepwise clearance of repressive roadblocks drives cardiac induction in human ESCs,\u201d (in eng)","volume":"18","author":"Rao","year":"2016","journal-title":"Cell Stem Cell"},{"issue":"3","key":"10.1016\/j.ymeth.2021.12.006_b0610","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1101\/gad.607311","article-title":"\u201cPluripotency factors regulate definitive endoderm specification through eomesodermin,\u201d (in eng)","volume":"25","author":"Teo","year":"2011","journal-title":"Genes Dev."},{"issue":"1","key":"10.1016\/j.ymeth.2021.12.006_b0615","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nprot.2012.150","article-title":"\u201cDirected cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt\/\u03b2-catenin signaling under fully defined conditions,\u201d (in eng)","volume":"8","author":"Lian","year":"2013","journal-title":"Nat. Protoc."},{"issue":"1","key":"10.1016\/j.ymeth.2021.12.006_b0620","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1083\/jcb.200507103","article-title":"\u201cSeeing is believing? A beginners' guide to practical pitfalls in image acquisition,\u201d (in eng)","volume":"172","author":"North","year":"2006","journal-title":"J. Cell Biol."},{"issue":"8","key":"10.1016\/j.ymeth.2021.12.006_b0625","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1161\/CIRCRESAHA.119.315862","article-title":"Cardiomyocyte maturation","volume":"126","author":"Guo","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.ymeth.2021.12.006_b0630","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3389\/fcell.2020.00178","article-title":"\u201cA brief review of current maturation methods for human induced pluripotent stem cells-derived cardiomyocytes,\u201d (in eng)","volume":"8","author":"Ahmed","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"issue":"3","key":"10.1016\/j.ymeth.2021.12.006_b0635","doi-asserted-by":"crossref","first-page":"107925","DOI":"10.1016\/j.celrep.2020.107925","article-title":"Metabolic maturation media improve physiological function of human iPSC-derived cardiomyocytes","volume":"32","author":"Feyen","year":"2020","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.ymeth.2021.12.006_b0640","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-23329-z","article-title":"\u201cGeneration of mature compact ventricular cardiomyocytes from human pluripotent stem cells,\u201d","volume":"12","author":"Funakoshi","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymeth.2021.12.006_b0645","series-title":"Robustness in Statistics","first-page":"201","article-title":"Robustness in the strategy of scientific model building","author":"Box","year":"1979"},{"issue":"8","key":"10.1016\/j.ymeth.2021.12.006_b0650","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/nmeth.2999","article-title":"Chemically defined generation of human cardiomyocytes","volume":"11","author":"Burridge","year":"2014","journal-title":"Nat. Methods"},{"issue":"11","key":"10.1016\/j.ymeth.2021.12.006_b0655","article-title":"<i>MRAS<\/i> Variants cause cardiomyocyte hypertrophy in patient-specific induced pluripotent stem cell-derived cardiomyocytes","volume":"12","author":"Higgins","year":"2019","journal-title":"Circulation: Genomic Precision Med."},{"issue":"8","key":"10.1016\/j.ymeth.2021.12.006_b0660","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1007\/s00424-019-02293-0","article-title":"\u201cHypertrophy of human embryonic stem cell\u2013derived cardiomyocytes supported by positive feedback between Ca2+ and diacylglycerol signals,\u201d","volume":"471","author":"Deisl","year":"2019","journal-title":"Pfl\u00fcgers Archiv \u2013 Eur. J. Physiol."},{"issue":"9","key":"10.1016\/j.ymeth.2021.12.006_b0665","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/nbt1327","article-title":"\u201cCardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts,\u201d (in eng)","volume":"25","author":"Laflamme","year":"2007","journal-title":"Nat. Biotechnol."},{"issue":"27","key":"10.1016\/j.ymeth.2021.12.006_b0670","doi-asserted-by":"crossref","first-page":"E1848","DOI":"10.1073\/pnas.1200250109","article-title":"Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling","volume":"109","author":"Lian","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"7194","key":"10.1016\/j.ymeth.2021.12.006_b0675","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/nature06894","article-title":"Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population","volume":"453","author":"Yang","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.ymeth.2021.12.006_b0680","doi-asserted-by":"crossref","unstructured":"B. Lin et al., \u201cHigh-purity enrichment of functional cardiovascular cells from human iPS cells,\u201d (in eng), Cardiovasc. Res., 95(3), 327-35, 2012, 10.1093\/cvr\/cvs185.","DOI":"10.1093\/cvr\/cvs185"}],"container-title":["Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1046202321002814?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1046202321002814?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T01:46:33Z","timestamp":1760924793000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1046202321002814"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":136,"alternative-id":["S1046202321002814"],"URL":"https:\/\/doi.org\/10.1016\/j.ymeth.2021.12.006","relation":{},"ISSN":["1046-2023"],"issn-type":[{"value":"1046-2023","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Measuring hypertrophy in neonatal rat primary cardiomyocytes and human iPSC-derived cardiomyocytes","name":"articletitle","label":"Article Title"},{"value":"Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymeth.2021.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}